Abeona Therapeutics (ABEO)
(Delayed Data from NSDQ)
$3.26 USD
+0.07 (2.19%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.26 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Abeona Therapeutics Inc. [ABEO]
Reports for Purchase
Showing records 81 - 87 ( 87 total )
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Transferring Coverage; Reiterating Buy and Instituting $17 Price Target
Provider: H.C. Wainwright & Co., Inc.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Licensed Vector for Fanconi Anemia Gene Therapy
Provider: Roth Capital Partners, Inc.
Analyst: PIROS E
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Orphan Gene Therapy Program to Enter Clinic by Year End; Reit Buy Rating and $15 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A